The boxed warning will highlight the risk of tardive dyskinesia, or involuntary and repetitive movements of the body, with long-term or high-
dose use of metoclopramide, even after the drugs are no longer taken.
Drugs that contain metoclopramide include Reglan tablets, Reglan oral disintegrating tablets, metoclopramide oral solution, and Reglan injection. More than 2 million Americans use these products, according to the FDA.